GHRH analogue combined with selective GH secretagogue in one vial.
CJC-1295/Ipamorelin is a research blend combining two mechanistically complementary GH-axis secretagogues. CJC-1295 is a GHRH analog that binds the pituitary GHRH receptor to amplify GH pulse amplitude and extend GH secretion via albumin binding (DAC modification). Ipamorelin is a selective GHS-R1a agonist that mimics ghrelin to stimulate pulsatile GH release without significant cortisol or prolactin elevation. Combined, the two compounds engage both the GHRH receptor and ghrelin receptor simultaneously, producing synergistic GH axis activity studied in pituitary and growth hormone research models. Supplied as lyophilized blend, ≥99% HPLC purity per component, LC-MS confirmed.
Lone Star Peptide ships same-day to research institutions across Texas — Houston, Dallas, Austin, San Antonio and beyond. Same-state logistics, faster delivery, and a supplier who understands the Texas research landscape.
Texas Availability
Lone Star Peptide Co. ships CJC-1295/Ipamorelin to all Texas addresses for growth hormone axis and pituitary secretagogue research. Same-day dispatch on orders placed before 3 PM CST from our Houston base — Houston, Dallas, Austin, San Antonio, Fort Worth, and every Texas research institution. All batches ship with Freedom Diagnostics COA, HPLC chromatogram, LC-MS identity confirmation, and endotoxin results.
⚠ FOR RESEARCH USE ONLY, CJC-1295 / Ipamorelin is supplied exclusively for in vitro and laboratory research applications. Not approved by the FDA for human consumption or therapeutic use. Not a drug, supplement, or medical treatment. Purchasers are responsible for compliance with all applicable regulations.
Research FAQ